Recent insider trading activity from Dubin Glenn, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2024 | C4 Therapeutics, Inc. | $CCCC | Dubin Glenn | Director | A | Common Stock | 1358 | $8.10 | 812,682.0000 | 0 | 0.17% | 0.00% |
| Jan. 2, 2024 | C4 Therapeutics, Inc. | $CCCC | Dubin Glenn | Director | A | Common Stock | 1687 | $6.52 | 811,324.0000 | 0 | 0.21% | 0.00% |